The Journal of Neuroscience, November 5, 2008, 28(45):11650-11661; doi:10.1523/JNEUROSCI.3024-08.2008
Previous Article | Next Article 
Neurobiology of Disease
Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
Sebastian Jimenez,1,3,4 *
David Baglietto-Vargas,2,3 *
Cristina Caballero,1,3,4 *
Ines Moreno-Gonzalez,2,3
Manuel Torres,1,3,4
Raquel Sanchez-Varo,2,3
Diego Ruano,1,3,4
Marisa Vizuete,1,3,4
Antonia Gutierrez,2,3 and
Javier Vitorica1,3,4
1Department Bioquímica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain, 2Department Biologia Celular, Genetica y Fisiologia. Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain, 3Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) 41013 Sevilla, Spain, 4Instituto de Biomedicina de Sevilla (IBiS)–Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain
Correspondence should be addressed to Javier Vitorica, Department Bioquímica, Bromatologia, Toxicologia y Medicina Legal, Facultad de Farmacia. Universidad de Sevilla, C/ Prof. Garcia Gonzalez 2, 41012 Sevilla, Spain. Email: vitorica{at}us.es
Although the microglial activation is concomitant to the Alzheimer's disease, its precise role (neuroprotection vs neurodegeneration) has not yet been resolved. Here, we show the existence of an age-dependent phenotypic change of microglial activation in the hippocampus of PS1xAPP model, from an alternative activation state with Aβ phagocytic capabilities (at 6 months) to a classic cytotoxic phenotype (expressing TNF-
and related factors) at 18 months of age. This switch was coincident with high levels of soluble Aβ oligomers and a significant pyramidal neurodegeneration. In vitro assays, using astromicroglial cultures, demonstrated that oligomeric Aβ42 and soluble extracts from 18-month-old PS1xAPP hippocampus produced a potent TNF-
induction whereas monomeric Aβ42 and soluble extract from 6- or 18-month-old control and 6-month-old PS1xAPP hippocampi produced no stimulation. This stimulatory effect was avoided by immunodepletion using 6E10 or A11. In conclusion, our results show evidence of a switch in the activated microglia phenotype from alternative, at the beginning of Aβ pathology, to a classical at advanced stage of the disease in this model. This change was induced, at least in part, by the age-dependent accumulation of extracellular soluble Aβ oligomers. Finally, these cytotoxic activated microglial cells could participate in the neuronal lost observed in AD.
Key words: Alzheimer; transgenic model; neuroinflammation; hippocampus Aβ plaques; oligomers; hippocampus
Received June 30, 2008;
revised Sept. 18, 2008;
accepted Sept. 27, 2008.
Correspondence should be addressed to Javier Vitorica, Department Bioquímica, Bromatologia, Toxicologia y Medicina Legal, Facultad de Farmacia. Universidad de Sevilla, C/ Prof. Garcia Gonzalez 2, 41012 Sevilla, Spain. Email: vitorica{at}us.es
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2008 28: i.
[Full Text]